Non-invasive test for bladder cancer

Israeli biotech Nucleix has raised more than $5 million to finance its test for early detection of bladder cancer. Nucleix uses epigenetics (tiny changes in a cell’s DNA) to identify cancer cells. In the future, the product could also be used to test for colon, lung and prostate cancers.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *